LncRNA SNHG1 regulates immune escape of renal cell carcinoma by targeting miR‐129‐3p to activate STAT3 and PD‐L1
P Tian, JX Wei, J Li, JK Ren… - Cell Biology …, 2021 - Wiley Online Library
Immune escape of renal cell carcinoma (RCC) impacts patient survival. However, the
molecular mechanism of long noncoding RNA (lncRNA) small nucleolar RNA host gene 1 …
molecular mechanism of long noncoding RNA (lncRNA) small nucleolar RNA host gene 1 …
[HTML][HTML] Identification of the prognosis value and potential mechanism of immune checkpoints in renal clear cell carcinoma microenvironment
G Liao, P Wang, Y Wang - Frontiers in oncology, 2021 - frontiersin.org
Background Kidney Renal Clear Cell Carcinoma (KIRC) is one of the most prevalent types
of cancer worldwide. KIRC has a poor prognosis and, to date, immunotherapy based on …
of cancer worldwide. KIRC has a poor prognosis and, to date, immunotherapy based on …
[HTML][HTML] Characterization of the basement membrane in kidney renal clear cell carcinoma to guide clinical therapy
X Xiong, C Chen, J Yang, L Ma, X Wang… - Frontiers in …, 2022 - frontiersin.org
Background Renal cell carcinoma (RCC) is the most common kidney cancer in adults.
According to the histological features, it could be divided into several subtypes, of which the …
According to the histological features, it could be divided into several subtypes, of which the …
Broadening drug design and targets to tumor microenvironment? Cancer-associated fibroblast marker expression in cancers and relevance for survival outcomes
Solid tumors have complex biology and structure comprising cancer cells, stromal cells, and
the extracellular matrix. While most therapeutics target the cancer cells, recent data suggest …
the extracellular matrix. While most therapeutics target the cancer cells, recent data suggest …
[HTML][HTML] Expression and prognostic significance of zinc fingers and homeoboxes family members in renal cell carcinoma
Zinc fingers and homeoboxes (ZHX) is a transcription repressor family that contains three
members; ZHX1, ZHX2, and ZHX3. Although ZHX family members have been associated …
members; ZHX1, ZHX2, and ZHX3. Although ZHX family members have been associated …
Telomere length in renal cell carcinoma: The Jekyll and Hyde biomarker of ageing of the kidney
M Morais, F Dias, AL Teixeira… - Cancer Management and …, 2020 - Taylor & Francis
Renal cell carcinoma (RCC) is a heterogeneous group of cancers where the clear cell
(ccRCC) is the most common and the most lethal. The absence of accurate diagnostic and …
(ccRCC) is the most common and the most lethal. The absence of accurate diagnostic and …
TLR3 serves as a prognostic biomarker and associates with immune infiltration in the renal clear cell carcinoma microenvironment
G Liao, J Lv, A Ji, S Meng, C Chen - Journal of Oncology, 2021 - Wiley Online Library
Background. Clear cell renal cancer (KIRC) is one of the most common cancers globally,
with a poor prognosis. TLRs play a vital role in anticancer immunity and the regulation of the …
with a poor prognosis. TLRs play a vital role in anticancer immunity and the regulation of the …
[PDF][PDF] RETRACTED ARTICLE: Effects of LncRNA HCP5/miR-214-3p/MAPK1 Molecular Network on Renal Cell Carcinoma Cells
JF Hao, P Chen, HY Li, YJ Li… - Cancer Management and …, 2020 - Taylor & Francis
Hao JF, Chen P, Li HY, Li YJ, Zhang YL. Cancer Manag Res. 2020; 12: 13347–13356 The
Editor and Publisher of Cancer Management and Research are retracting the published …
Editor and Publisher of Cancer Management and Research are retracting the published …
Unraveling LGALS1 as a potential immune checkpoint and a predictor of the response to anti-PD1 therapy in clear cell renal carcinoma
Y Li, S Yang, H Yue, D Yuan, L Li, J Zhao… - Pathology & Oncology …, 2020 - Springer
Immunotherapy base on immune checkpoint inhibitor had obtained significant progress in
extending the survival of clear cell renal carcinoma (ccRCC) patients. In order to further …
extending the survival of clear cell renal carcinoma (ccRCC) patients. In order to further …
External validation of the VENUSS prognostic model to predict recurrence after surgery in non-metastatic papillary renal cell carcinoma: a multi-institutional analysis
Abstract Objective Recently, VENUSS (VEnous extension, NUclear Grade, Size, Stage), as a
prognostic model, was defined to predict disease recurrence (DR) after curative surgery of …
prognostic model, was defined to predict disease recurrence (DR) after curative surgery of …